Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Seroprevalence and distribution of leptospirosis serovars among wet market workers in northeastern, Malaysia: a cross sectional study

Authors: Mas Harithulfadhli Agus Ab Rahman, Suhaily Mohd Hairon, Rukman Awang Hamat, Tengku Zetty Maztura Tengku Jamaluddin, Mohd Nazri Shafei, Norazlin Idris, Malina Osman, Surianti Sukeri, Zainudin A. Wahab, Wan Mohd Zahiruddin Wan Mohammad, Zawaha Idris, Aziah Daud

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

Leptospirosis is a zoonotic disease associated with occupations which exposed workers to environments contaminated with urine of infected animals. The objective of this study was to determine the seroprevalence of leptospirosis among wet market workers in Kelantan.

Methods

A cross sectional study was conducted in two main wet markets in Kelantan and 232 wet market workers were randomly selected. Blood samples were analysed for microscopic agglutination test (MAT) against 20 live leptospirosis reference serovars. MAT titres of 1:100 or more were considered as seropositive.

Results

It was found that the overall seroprevalence for leptospirosis among the respondents was 33.6% (95% CI = 27.5, 39.7). The samples were tested positive against serovars Melaka (IMR LEP 1), Terengganu (IMR LEP 115), Sarawak (IMR LEP 175), Copenhageni (IMR LEP 803/11), Hardjobovis (IMR LEP 27), Australis, Autumnalis, Bataviae, Canicola, Grippotyphosa, Hardjoprajitno, Icterohaemorrhagiae, Javanica, Pyrogenes, Terrasovi, Djasiman, Patoc and Pomona. The predominant serovars was Autumnalis (18.2%).

Conclusion

Wet markets workers were at risk for leptospirosis infection evidenced by high seroprevalence of leptospirosis in this study. Further research need to be conducted to determine factors that favours infection in this groups.
Literature
2.
go back to reference El Jalii IM, Bahaman AR. A review of human leptospirosis in Malaysia. Trop Biomed. 2004;21(2):113–9.PubMed El Jalii IM, Bahaman AR. A review of human leptospirosis in Malaysia. Trop Biomed. 2004;21(2):113–9.PubMed
6.
go back to reference Hartskeerl RA. Leptospirosis: current status and future trends. Indian J Med Microbiol. 2006;24(4):309.CrossRef Hartskeerl RA. Leptospirosis: current status and future trends. Indian J Med Microbiol. 2006;24(4):309.CrossRef
10.
14.
go back to reference WHO. WHO guidelines on drawing blood: best practices in phlebotomy. Geneva: Switzerland; 2010. WHO. WHO guidelines on drawing blood: best practices in phlebotomy. Geneva: Switzerland; 2010.
15.
go back to reference Shafei MN, Sulong MR, Yaacob NA, Hassan H, Wan Mohd Zahiruddin W, Aziah D, et al. Seroprevalence of leptospirosis among town service workers on northeastern state of Malaysia. International Journal of Collaborative Research on Internal Medicine & Public Health. 2012;4:395–403. Shafei MN, Sulong MR, Yaacob NA, Hassan H, Wan Mohd Zahiruddin W, Aziah D, et al. Seroprevalence of leptospirosis among town service workers on northeastern state of Malaysia. International Journal of Collaborative Research on Internal Medicine & Public Health. 2012;4:395–403.
Metadata
Title
Seroprevalence and distribution of leptospirosis serovars among wet market workers in northeastern, Malaysia: a cross sectional study
Authors
Mas Harithulfadhli Agus Ab Rahman
Suhaily Mohd Hairon
Rukman Awang Hamat
Tengku Zetty Maztura Tengku Jamaluddin
Mohd Nazri Shafei
Norazlin Idris
Malina Osman
Surianti Sukeri
Zainudin A. Wahab
Wan Mohd Zahiruddin Wan Mohammad
Zawaha Idris
Aziah Daud
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3470-5

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.